Mutations and variants of ONECUT1 in diabetes
Male
Pluripotent Stem Cells
0301 basic medicine
Multifactorial Inheritance
Biomedical and clinical sciences
Transcription, Genetic
Organogenesis
Immunology
610
Regenerative Medicine
Autoimmune Disease
Medical and Health Sciences
Congenital Abnormalities
03 medical and health sciences
Genetic
Clinical Research
[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
Genetics
Diabetes Mellitus
2.1 Biological and endogenous factors
Humans
Stem Cell Research - Embryonic - Human
Pancreas
Metabolic and endocrine
Pediatric
Homeodomain Proteins
[SDV.GEN]Life Sciences [q-bio]/Genetics
Fetal Growth Retardation
Biomedical and Clinical Sciences
Stem Cell Research - Induced Pluripotent Stem Cell - Human
Stem Cell Research - Induced Pluripotent Stem Cell
Diabetes
Infant, Newborn
Health sciences
Gallbladder
Infant
Pancreatic Diseases
Cell Differentiation
Stem Cell Research
Newborn
3. Good health
Hepatocyte Nuclear Factor 6
Homeobox Protein Nkx-2.2
Diabetes Mellitus, Type 2
Transcription
Type 2
DOI:
10.1038/s41591-021-01502-7
Publication Date:
2021-10-19T00:13:50Z
AUTHORS (40)
ABSTRACT
Genes involved in distinct diabetes types suggest shared disease mechanisms. Here we show that One Cut Homeobox 1 (ONECUT1) mutations cause monogenic recessive syndromic diabetes in two unrelated patients, characterized by intrauterine growth retardation, pancreas hypoplasia and gallbladder agenesis/hypoplasia, and early-onset diabetes in heterozygous relatives. Heterozygous carriers of rare coding variants of ONECUT1 define a distinctive subgroup of diabetic patients with early-onset, nonautoimmune diabetes, who respond well to diabetes treatment. In addition, common regulatory ONECUT1 variants are associated with multifactorial type 2 diabetes. Directed differentiation of human pluripotent stem cells revealed that loss of ONECUT1 impairs pancreatic progenitor formation and a subsequent endocrine program. Loss of ONECUT1 altered transcription factor binding and enhancer activity and NKX2.2/NKX6.1 expression in pancreatic progenitor cells. Collectively, we demonstrate that ONECUT1 controls a transcriptional and epigenetic machinery regulating endocrine development, involved in a spectrum of diabetes, encompassing monogenic (recessive and dominant) as well as multifactorial inheritance. Our findings highlight the broad contribution of ONECUT1 in diabetes pathogenesis, marking an important step toward precision diabetes medicine.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (75)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....